Literature DB >> 3125969

Anticancer drugs: second malignancies--risk reduction.

E Petru1, D Schmähl.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3125969     DOI: 10.1016/0305-7372(87)90027-2

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  3 in total

1.  [Janus-faced character of chemotherapy: a comment on the Abel theses].

Authors:  D Schmähl
Journal:  Klin Wochenschr       Date:  1991-01-04

Review 2.  Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer.

Authors:  K L Dechant; R N Brogden; T Pilkington; D Faulds
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.